Characterizing Patients with Very-Low-Level HIV Viremia: A Community-Based Study - Wikidata - awgldk - TriplyDB

Characterizing Patients with Very-Low-Level HIV Viremia: A Community-Based Study

Characterizing Patients with Very-Low-Level HIV Viremia: A Community-Based Study

http://www.wikidata.org/entity/Q33653518

about

Characterizing Patients with Very-Low-Level HIV Viremia: A Community-Based Study

http://www.wikidata.org/entity/Q33653518

description

2016 nî lūn-bûn

@nan

2016 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Characterizing Patients with Very-Low-Level HIV Viremia: A Community-Based Study

@ast

Characterizing Patients with Very-Low-Level HIV Viremia: A Community-Based Study

@en

type

label

Characterizing Patients with Very-Low-Level HIV Viremia: A Community-Based Study

@ast

Characterizing Patients with Very-Low-Level HIV Viremia: A Community-Based Study

@en

prefLabel

Characterizing Patients with Very-Low-Level HIV Viremia: A Community-Based Study

@ast

Characterizing Patients with Very-Low-Level HIV Viremia: A Community-Based Study

@en

P1433

Q33653518-9FFDACC5-73C1-4EEF-9B70-D8673152FEE1

P1476

Q33653518-2F751F42-6A70-4CF7-984A-4CE9585B209A

P2093

Q33653518-47ABA5C8-3C0A-4CA4-963D-D2EF163E6A71

Q33653518-82250784-748F-4274-81D4-68EE4AA3264A

Q33653518-9C747D8F-97C9-4FE5-9CEE-904FC94B8B95

Q33653518-BD237153-288F-4F16-B08A-4C976C7B8203

Q33653518-D61B0BDF-C273-4E25-9E45-1BD867ABB9FE

P2860

Q33653518-0085D139-EF74-484F-BB6D-D02A06C9720E

Q33653518-0FD9EAF4-7944-44CA-9C1E-F0E14882D2A7

Q33653518-17158F34-111C-4DDA-A9E0-0296262F8C5D

Q33653518-24C31E7A-1F50-45A3-B8F2-0CB18751D6C5

Q33653518-24D7BB9D-5C79-453E-8D18-643F36841F94

Q33653518-2CDCA3E9-C450-498F-9D70-FC0AB30D892A

Q33653518-2D108E11-B67E-493D-98B3-3E359DAFF77B

Q33653518-38352E6E-48E2-46AE-9942-DE37B9573035

Q33653518-3A2C8E0A-128E-43E4-85A9-A6987E13E941

Q33653518-46E04A6C-0BFD-4E44-ADF1-47B60410F0A3

P304

Q33653518-4DA13D46-9F2B-4408-A3C0-2A77BBE7FB9C

P31

Q33653518-EFE1D313-C402-46FA-BE88-1FC5D2879DB6

P356

Q33653518-7B7B5708-207B-414F-848E-C8063DCDF7F2

P433

Q33653518-ECFA1F6D-D724-45F7-9F32-C51D6346A5F5

P478

Q33653518-CDF8F5D7-22A7-4711-B6FD-4A9722F1DF43

P50

Q33653518-7E5E8990-756D-4D8B-B4DA-56729E406A0F

P577

Q33653518-2546CDA3-6E6A-41C0-B17E-DB015E8E6285

P698

Q33653518-A4C205FF-D43C-4349-AA1D-EDCB5FC8EF0E

P932

Q33653518-6AE6FB56-E3A1-4B43-97E4-41630D940AE9

P356

2325957416680028

P1433

Journal of the International Association of Providers of AIDS Care

P1476

Characterizing Patients with Very-Low-Level HIV Viremia: A Community-Based Study

@en

P2093

Elie Helou

http://www.w3.org/2001/XMLSchema#string

Lydia Aoun Barakat

http://www.w3.org/2001/XMLSchema#string

Marie-Louise Landry

http://www.w3.org/2001/XMLSchema#string

Sheela Shenoi

http://www.w3.org/2001/XMLSchema#string

Tassos Kyriakides

http://www.w3.org/2001/XMLSchema#string

P2860

Evaluation of the Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 test and identification of rare polymorphisms potentially affecting assay performance

Factors Associated with Low-Level Viraemia and Virological Failure: Results from the Austrian HIV Cohort Study

Low-level HIV-1 replication and the dynamics of the resting CD4+ T cell reservoir for HIV-1 in the setting of HAART.

HIV-1 residual viremia correlates with persistent T-cell activation in poor immunological responders to combination antiretroviral therapy.

Significance and clinical management of persistent low-level viremia and very-low-level viremia in HIV-1-infected patients.

Detection of HIV-1 at between 20 and 49 copies per milliliter by the Cobas TaqMan HIV-1 v2.0 assay is associated with higher pretherapy viral load and less time on antiretroviral therapy.

HIV-infected individuals receiving effective antiviral therapy for extended periods of time continually replenish their viral reservoir.

Increased risk of virologic rebound in patients on antiviral therapy with a detectable HIV load <48 copies/mL

Quantification of viral loads lower than 50 copies per milliliter by use of the Cobas AmpliPrep/Cobas TaqMan HIV-1 test, version 2.0, can predict the likelihood of subsequent virological rebound to >50 copies per milliliter.

Factors associated with adherence amongst 5295 people receiving antiretroviral therapy as part of an international trial

P304

261-266

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/2325957416680028

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P50

Michael J Kozal

P577

2016-11-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27903948

http://www.w3.org/2001/XMLSchema#string

P932

5423832

http://www.w3.org/2001/XMLSchema#string